Ikofficial Ikofficial
Zoekresultaten
Alle resultaten weergeven
  • Registreer
    Log in
    Creëer je account
    Zoeken
    Night Mode

Zoeken

Ontdek nieuwe mensen, nieuwe verbindingen te maken en nieuwe vrienden maken

  • Nieuws Feed
  • EXPLORE
  • Pagina
  • Groepen
  • Events
  • Blogs
  • Offers
  • Jobs
  • Courses
  • Forums
  • Berichten
  • Blogs
  • Gebruikers
  • Pagina
  • Groepen
  • Events
  • Ruchika Thakur toegevoegd een audio Other
    2026-06-30 05:49:41 -
    Global Monoclonal Antibody Market Size, Trends, Opportunities & Forecast 2035
    Monoclonal Antibody Market Overview According to MarketGenics, the global Monoclonal Antibody Market is witnessing remarkable growth, driven by increasing demand for targeted therapies, rising prevalence of chronic diseases, and rapid advancements in biotechnology. The market is expected to expand significantly throughout the forecast period as pharmaceutical companies continue investing in...
    0 Reacties 0 aandelen 34 Views 0 voorbeeld
    Please log in to like, share and comment!
  • Subhayan Mayra toegevoegd een audio Other
    2026-06-24 13:17:02 -
    Global Pembrolizumab Market Growing at 7.3% CAGR Through 2034
    According to a new report from Intel Market Research, the global Pembrolizumab market was valued at USD 21.8 billion in 2025 and is projected to grow from USD 24.3 billion in 2026 to USD 42.7 billion by 2034, exhibiting a robust CAGR of 7.3% during the forecast period. This growth is driven by increasing cancer prevalence, rising immunotherapy adoption, expanding regulatory approvals for new...
    0 Reacties 0 aandelen 216 Views 0 voorbeeld
    Please log in to like, share and comment!
  • Subhayan Mayra toegevoegd een audio Other
    2026-06-12 10:21:20 -
    United States ADC for Solid Tumors Market Growing at 8.9% CAGR Through 2034
    The United States Antibody‑Drug Conjugate (ADC) for Solid Tumors market size was valued at approximately USD 0.55 billion in 2025. The market is projected to grow from approximately USD 0.58 billion in 2026 to around USD 1.04 billion by 2034, exhibiting a CAGR of about 8.9% during the forecast period. Antibody‑Drug Conjugates are targeted therapeutics that combine a monoclonal antibody that...
    0 Reacties 0 aandelen 564 Views 0 voorbeeld
    Please log in to like, share and comment!
© 2026 Ikofficial Dutch
English Arabic French Spanish Portuguese Deutsch Turkish Dutch Italiano Russian Romaian Portuguese (Brazil) Greek
About Voorwaarden Privacy Contact Us Bedrijvengids